Methylphenidate

Oral route(Tablet, Extended Release, Disintegrating)

CNS stimulants, including methylphenidate extended-release orally disintegrating tablets, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing, and monitor for signs of abuse and dependence while on therapy .

Oral route(Powder for Suspension, Extended Release;Tablet, Extended Release Chewable;Capsule, Extended Release;Tablet;Tablet, Extended Release;Solution)

Warning: Abuse and DependenceCNS stimulants, including methylphenidate hydrochloride, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing, and monitor for signs of abuse and dependence while on therapy .

Oral route(Tablet, Extended Release;Tablet, Chewable)

Warning: Drug DependenceMethylphenidate hydrochloride should be given cautiously to emotionally unstable patients , such as those with history of drug dependence or alcoholism , because such patient may increase dosage on their own initiative .Chronic abusive use can lead to marked tolerance and psychological dependence with varying degrees of abnormal behavior. Frank psychotic episodes can occur, especially with parenteral abuse. Careful supervision is required during withdrawal from abusive use since severe depression , as well as the effects of chronic overactivity can occur. Withdrawal following chronic therapeutic use may unmask symptoms of the underlying disorder that may require follow up .Long-term follow-up may be required because of the patient's basic personality disturbances .